Antiviral Therapy for a Postpartum Flare in Women with Chronic HBV Infection Shortens the ALT Recovery Time and Reduces Hepatitis Re-Flare Rates within 4 years
Table 3
Prognosis of the women postpartum 4 years.
characteristics
NAT-G (n = 46) n/%, M (P25, P75)
AT-G (n = 38) n/%, M (P25, P75)
Z/x2
ALT (U/L)
16.6 (11.65, 27.8)
27.4 (15.15, 36.65)
4.065
HBsAg (S/CO)
53786 (29982.49, 69098.77)
2712.85 (847.54, 4675.69)
5.527
HBeAg (S/CO)
1398 (1100, 33)
3.6 5 (0.39, 23.07)
6.123
HBeAg loss proportion
n = 2 (4.34%)
n = 7 (18.91%)
4.599
0.040
HBV DNA (log IU/mL)
8.23 (7.78, 8.23)
<2 (<Detectionlimit)
7.941
HBV DNA
n = 1 (2.17%)
n = 35 (92.1%)
68.723
ALT, alanine aminotransferase; HBeAg, hepatitis B e antigen; HBsAg, hepatitis B surface antigen; HBV DNA, hepatitis B deoxyribonucleic acid.
